TCG Crossover Management

TCG Crossover Management as of June 30, 2024

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 32 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cg Oncology Comm (CGON) 12.1 $116M 3.7M 31.57
Dyne Therapeutics Comm (DYN) 9.7 $94M 2.7M 35.29
Abivax SA Adrs (ABVX) 8.3 $80M 6.1M 13.22
Silence Therapeutics Adrs (SLN) 6.5 $63M 3.3M 19.00
Cogent Biosciences Comm (COGT) 6.1 $59M 7.0M 8.43
Savara Comm (SVRA) 5.2 $50M 12M 4.03
Madrigal Pharmaceuticals Comm (MDGL) 4.4 $42M 149k 280.16
Edgewise Therapeutics Comm (EWTX) 4.3 $41M 2.3M 18.01
Keros Therapeutics Comm (KROS) 4.2 $40M 879k 45.70
Mineralys Therapeutics Comm (MLYS) 3.9 $37M 3.2M 11.70
Ocular Therapeutix Comm (OCUL) 3.8 $36M 5.3M 6.84
Tyra Biosciences Comm (TYRA) 3.3 $32M 2.0M 15.99
Kura Oncology Comm (KURA) 3.1 $29M 1.4M 20.59
Structure Therapeutics Adrs (GPCR) 2.8 $27M 695k 39.27
Centessa Pharmaceuticals Comm (CNTA) 2.7 $26M 2.9M 9.03
Astria Therapeutics Comm 2.6 $25M 2.8M 9.10
Compass Pathways Adrs (CMPS) 2.4 $23M 3.9M 6.04
Soleno Therapeutivs Comm 2.3 $22M 550k 40.80
Disc Medicine Comm (IRON) 2.3 $22M 487k 45.07
Tourmaline Bio Comm (TRML) 2.0 $19M 1.5M 12.86
Tarsus Pharmaceuticals Comm (TARS) 1.6 $15M 556k 27.18
Adverum Biotechnologies Comm 1.4 $14M 2.0M 6.86
Vistagen Therapeutics Comm 1.0 $9.3M 2.7M 3.48
Entrada Therapeutics Comm (TRDA) 0.9 $8.3M 585k 14.25
EyePoint Pharmaceuticals Comm (EYPT) 0.8 $8.0M 922k 8.70
C4 Therapeutics Comm (CCCC) 0.6 $5.9M 1.3M 4.62
Nektar Therapeutics Comm 0.5 $5.0M 4.0M 1.24
Aerovate Therapeutics Comm (AVTE) 0.4 $3.7M 2.2M 1.66
AN2 Therapeutics Comm (ANTX) 0.3 $3.3M 1.6M 2.15
Kodiak Sciences Comm (KOD) 0.2 $2.1M 900k 2.35
Ventyx Biosciences Comm (VTYX) 0.1 $730k 316k 2.31
Cabaletta Bio Comm (CABA) 0.1 $649k 87k 7.48